Seven functional polymorphisms in the CETP gene and myocardial infarction risk: A meta-analysis and meta-regression

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wang, Qi ^a   Zhou, Shao Bo ^a   Wang, Li Jie ^a   Lei, Ming Ming ^a   Wang, Yong ^a   Miao, Chi ^a   Jin, Yuan Zhe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOSINE; GUANINE; THYMINE; CETP PROTEIN, HUMAN; GENETIC MARKER;

ARTICLE; CAUCASIAN; CETP GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; META ANALYSIS (TOPIC); POPULATION BASED CASE CONTROL STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ALLELE; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; RISK FACTOR;

ALLELES; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; COHORT STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84895756052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088118     Document Type: Article

References (55)

1. White HD, Chew DP (2008) Acute myocardial infarction. Lancet, 372(9638): 570-584.
2. Manrique-Garcia E, Sidorchuk A, Hallqvist J, Moradi T (2011) Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis. J Epidemiol Community Health, 65(4): 301-309.
3. Ohki T, Itabashi Y, Kohno T, Yoshizawa A, Nishikubo S, et al (2012) Detection of periodontal bacteria in thrombi of patients with acute myocardial infarction by polymerase chain reaction. Am Heart J, 163(2): 164-167.
4. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, et al (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. New Engl J Med, 347(24): 1916-1923. (Pubitemid 35429921)
5. Licastro F, Chiappelli M, Porcellini E, Campo G, Buscema M, et al (2010) Gene-gene and gene-clinical factors interaction in acute myocardial infarction: a new detailed risk chart. Curr Pharm Des, 16(7): 783-788.
6. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, et al (2010) Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J, 31(6): 737-746.
7. Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, et al (2011) Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA, 306(19): 2120-2127.
8. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 380(9841): 572-580.
9. Vinueza R, Boissonnet CP, Acevedo M, Uriza F, Benitez FJ, et al (2010) Dyslipidemia in seven Latin American cities: CARMELA study. Preventive medicine, 50(3): 106-111.
10. Poss J, Custodis F, Werner C, Weingartner O, Bohm M, et al (2011) Cardiovascular disease and dyslipidemia: beyond LDL. Current pharmaceutical design, 17(9): 861-870.
11. Holzmann MJ, Jungner I, Walldius G, Ivert T, Nordqvist T, et al (2012) Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease. Annals of medicine, 44(3): 262-270.
12. Masson D, Jiang X-C, Lagrost L, Tall AR (2009) The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. Journal of lipid research, 50(Supplement): S201-S206.
13. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH (2009) The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. Journal of lipid research, 50(Supplement): S189-S194.
14. Tall AR (2010) Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. J Clin Lipidol, 4(5): 389-393.
15. Cooney M, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, et al (2009) HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis, 206(2): 611-616.
16. von Eckardstein A (2010) Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target? Expert Rev Cardiovasc Ther, 8(3): 345-358.
17. Qian Y, Pu Y, Liu L, Wang DZ, Zhao X, et al (2013) Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study. PLoS One, 8(5): e64395.
18. Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, et al (2013) Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation, 128(14): 1504-1512.
19. Barn K, Laftavi M, Pierce D, Ying C, Boden WE, et al (2010) Low levels of highdensity lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipients. Transpl Int, 23(6): 574-579.
20. Wu JH, Lee YT, Hsu HC, Hsieh LL (2001) Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis, 159(2): 451-458. (Pubitemid 33127259)
21. Ridker PM, Paré G, Parker AN, Zee RY, Miletich JP, et al (2009) Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction Genomewide Analysis Among 18 245 Initially Healthy Women From the Women's Genome Health Study. Circ Cardiovasc Genet, 2(1): 26-33.
22. Thompson JF, Durham LK, Lira ME, Shear C, Milos PM (2005) CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis, 181(1): 45-53.
23. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, et al (1987) Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature, 327(6123): 632-634. (Pubitemid 17086900)
24. Ordovas JM (2000) Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): should we be measuring them? Clin Chem Lab Med, 38(10): 945-949.
25. van Venrooij FV, Stolk RP, Banga J-D, Sijmonsma TP, van Tol A, et al (2003) Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diabetes Care, 26(4): 1216-1223. (Pubitemid 36929275)
26. Dullaart RP, Sluiter WJ (2008) Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics 2008 Jun, 9(6):747-763.
27. Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, et al (2005) TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia. Eur J Hum Genet, 13(7): 877-882. (Pubitemid 40946087)
28. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M (2000) New Functional Promoter Polymorphism, CETP/2 629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels Role of Sp1/Sp3 in Transcriptional Regulation. Arterioscler Thromb Vasc Biol, 20(2): 507-515. (Pubitemid 30086110)
29. Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, et al (2001) The 2629C.A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis, 159(1): 187-192. (Pubitemid 33019216)
30. Keavney B, Palmer A, Parish S, Clark S, Youngman L, et al (2004) Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol, 33(5): 1002-1013. (Pubitemid 39429993)
31. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, et al (2004) Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J, 25(6): 459-467. (Pubitemid 38524270)
32. Meiner V, Friedlander Y, Milo H, Sharon N, Ben-Avi L, et al (2008) Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction. Ann Hum Genet, 72(Pt 6): 732-741.
33. Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, et al (2002) A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis, 161(2): 469-474. (Pubitemid 34219203)
34. Andrikopoulos GK, Richter DJ, Needham EW, Zairis MN, Karabinos EN, et al (2004) Association of the ile405val mutation in cholesteryl ester transfer protein gene with risk of acute myocardial infarction. Heart, 90(11): 1336-1337. (Pubitemid 39434005)
35. Zhang GB, Jiang ZW, Sun BG, Lu YS, Wen QZ, et al (2005) Relationship of Taq IB Polymorphism in the Cholesteryl Ester Transfer Protein Gene to Coronary Artery Disease. Chin J Arterioscler, (01): 88-90.
36. Li Y, Guo JX, Li JP, Fang YP, Guan BX, et al (1999) Association between cholesterol ester transfer protein gene polymorphism with myocardial infarction. Chin Circul J, (03): 16.
37. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25(9): 603-605.
38. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med, 31(29): 3805-3820.
39. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295(6): 676-680. (Pubitemid 43209069)
40. Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. BMJ, 336(7658): 1413-1415.
41. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics, 21(18): 3672-3673. (Pubitemid 41264106)
42. Tenkanen H, Koshinen P, Kontula K, Aalto-Setala K, Manttari M, et al (1991) Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet, 87(5): 574-578.
43. Zhuang Y, Wang J, Qiang H, Li Y, Liu X, et al (2002) Cholesteryl ester transfer protein levels and gene deficiency in Chinese patients with cardio-cerebrovascular diseases. Chin Med J (Engl), 115(3): 371-374.
44. Enquobahrie DA, Smith NL, Bis JC, Carty CL, Rice KM, et al (2008) Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am J Cardiol, 101(12): 1683-1688.
45. Zee RY, Cook NR, Cheng S, Erlich HA, Lindpaintner K, et al (2006) Multilocus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost, 4(2): 341-348.
46. Barter P (2000) CETP and atherosclerosis. Arterioscler Thromb Vasc Biol, 20(9): 2029-2031.
47. Zhang L, Yan F, Zhang S, Lei D, Charles MA, et al (2012) Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat Chem Biol, 8(4): 342-349.
48. Banka CL (1996) High density lipoprotein and lipoprotein oxidation. Curr Opin Lipidol, 7(3): 139-142.
49. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM (2004) Anti-inflammatory properties of HDL. Reviews in Endocrine and Metabolic Disorders, 5(4): 351-358. (Pubitemid 39388752)
50. de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, et al (2002) Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans a randomized phase II dose-response study. Circulation, 105(18): 2159-2165. (Pubitemid 34517159)
51. Rich MW (2009) Epidemiology of atrial fibrillation. J Interv Card Electrophysiol, 25(1): 3-8.
52. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature, 415(6868): 219-226.
53. Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet, 15 Spec No 2: R117-123. (Pubitemid 44446784)
54. Serre D, Montpetit A, Pare G, Engert JC, Yusuf S, et al (2008) Correction of population stratification in large multi-ethnic association studies. PLoS One, 3(1): e1382.
55. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283(15): 2008-2012. (Pubitemid 30214957)